On October 5 and 6, 2018, Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine will take place. Here, ADIPOA-2 Coordinator Prof Frank Barry of the Regenerative Medicine Institute at the National University of Ireland Galway will deliver a keynote presentation, ‘Cell Strategies for Arthritic Disease’. Zoobiquity Colorado aims to uncover the astonishing connection between human and […]
This author has yet to write their bio.Meanwhile lets just say that we are proud aoife contributed a whooping 27 entries.
Entries by aoife
ADIPOA-2 Coordinator Professor Frank Barry of NUI Galway has had a busy 2018 thus far. He has organised and been invited to present at several conferences, provide keynote talks and lead seminars around the world raising the profile of ADIPOA-2 internationally within academic and industrial circles. Here is a list of events: Speaker on August 17 […]
On pages 8-12 of the June 2018 Informasanità, the Azienda Ospedaliera di Padova newsletter, ADIPOA-2 is featured. The role within the project and the team at the Rheumatology Unit, Department of Medicine – DIMED, University of Padova (UNIPD) are highlighted. Read the entire publication here: INFORMASANITA-GIUGNO-2018 Read more about the Rheumatology Unit of the Department of Medicine (DIMED) of University of […]
Leaders in industry and science met and discussed recent advances in cell and gene therapy research and development at an industry-focused event held on Thursday, June 28, 2018, at the Meyrick Hotel in Galway, Ireland. Industry representation included presentations from Takeda, ReNeuron, Avectas and Valitacell. ADIPOA-2 Coordinator Prof Frank Barry presented the project’s mission, progress […]
EU funded projects ADIPOA-2, AUTOSTEM, NEPHSTROM and VISICORT coordinated by the Regenerative Medicine Institute (REMEDI) at National University of Ireland, Galway exhibited at a unique outreach activity targeted at primary school students. The event called the START competition was the brainchild of the Health Research Board (Ireland)’s Trials Methodology Research Network (HRB-TMRN) in Galway. In […]
On March 29, 2018, the online magazine Il Bo published an update on the ADIPOA-2 clinical trial ongoing at the University of Padua and other sites. Read the story here.
‘Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis’ by authors: Stella Cosenza, Maxime Ruiz, Karine Toupet, Christian Jorgensen & Danièle Noël was published online on 24 November 2017 in the open access Nature publication Scientific Reports. Abstract: Mesenchymal stem or stromal cells (MSCs) exert chondroprotective effects in preclinical models of osteoarthritis (OA). Most […]
ADIPOA-2 researchers at NUI Galway exhibited at the Galway Science and Technology Forum on 26 November 2017. In excess of 20,000 people attended the exhibition day. The NUI Galway regenerative medicine stand was the brainchild of Dr Siobhán Gaughan who works across several EU-funded stem cell projects coordinated at NUI Galway. Researchers Georgina Shaw, Amy Burke […]
Does it help your fitness to have an event as a goal when you are training? Can cartoons and comics help children to achieve better results in tests? How would you even find out? Dr Siobhán Gaughan, NUI Galway Programmme Manager of ADIPOA-2, VISICORT and AUTOSTEM was on hand at the awards ceremony for a […]
Hosted by Leiden University Medical Center, the EU MSC2 2017 meeting in Leiden, NL on September 12th and 13th will assemble twelve EU-funded, mesenchymal stromal cell-focussed consortia. Projects to be presented include: REDDSTAR, REACH, Nephstrom, SCIENCE, VISICORT and Adipoa-2, AUTOSTEM, BOOSTB4, SEPCELL, RESSTORE, RETHRIM, Stellar, MERLIN, and RESPINE. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden. Three overarching aspects of the EU-MSC2 meeting include: mechanisms […]
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643809. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.